Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women.

MLA

Tankó, László B., et al. “Effective Doses of Ibandronate Do Not Influence the 3-Year Progression of Aortic Calcification in Elderly Osteoporotic Women.” Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, vol. 16, no. 2, Feb. 2005, pp. 184–90. EBSCOhost, https://doi.org/10.1007/s00198-004-1662-x.

APA

Tankó, L. B., Qin, G., Alexandersen, P., Bagger, Y. Z., & Christiansen, C. (2005). Effective doses of ibandronate do not influence the 3-year progression of aortic calcification in elderly osteoporotic women. Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA, 16(2), 184–190. https://doi.org/10.1007/s00198-004-1662-x

Chicago

Tankó, László B, Gerong Qin, Peter Alexandersen, Yu Z Bagger, and Claus Christiansen. 2005. “Effective Doses of Ibandronate Do Not Influence the 3-Year Progression of Aortic Calcification in Elderly Osteoporotic Women.” Osteoporosis International : A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 16 (2): 184–90. doi:10.1007/s00198-004-1662-x.